Living condition | | |
Independent | 93.4 | 94.9 |
Institutionalised | 6.6 | 5.1 |
Living situation | | |
With partner or other | 68.7 | 69.1 |
Alone | 31.3 | 30.9 |
Comorbidity | | |
Cardiac | 35.7 | 36.4 |
Respiratory | 14.7 | 17.2 |
Diabetes | 16.8 | 16.2 |
Neurological* | 10.6 | 12.1 |
Locomotion | 35.7 | 37.6 |
Cancer | 7.7 | 3.5 |
Visual | 10.7 | 10.1 |
Auditive | 14.1 | 15.7 |
Other | 22.9 | 18.2 |
Functional status | | |
BI (median, IQR) | NA | 20 (19–20) |
Independent | | 67.2 |
Dependent | | 32.8 |
FAI (median, IQR) | 41 (33–46) | 41 (34–46) |
Inactive | 18.1 | 17.9 |
Active | 47.7 | 50.0 |
Very active | 34.2 | 32.1 |
mRS (median, IQR) | NA | 1 (1–3) |
0 | | 19.2 |
1 | | 34.8 |
2 | | 20.2 |
3 | | 22.2 |
4 | | 3.5 |
Use of drugs | | |
Aspirin | 65.2 | 67.0 |
Anticoagulants | 15.5 | 11.7 |
Other | 9.5 | 11.2 |
None | 9.8 | 10.1 |
Use of healthcare facilities | | |
Treatment | 19.1 | 18.1 |
ADL care | 26.4 | 19.3 |
Psychosocial care | 3.2 | 1.2 |
Adjustments | 32.3 | 28.2 |